NovaBridge Biosciences Capital Expenditures
NovaBridge Biosciences (NBP) reported Capital Expenditures of $7.00 thousand for the 12-month period ending 2025-12-31, per its 20-F filed 2026-04-07.
Financial Statements › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquirePropertyPlantAndEquipment · last filed 2026-04-07
- NovaBridge Biosciences payments to acquire property, plant, and equipment for the quarter ending 2020-12-31 was 3.25M CNY, a 57.41% decline year-over-year.
- NovaBridge Biosciences payments to acquire property, plant, and equipment for the quarter ending 2019-12-31 was 7.62M CNY.
CNY
| Period end | Payments to Acquire Property, Plant, and Equipment 3 month | Payments to Acquire Property, Plant, and Equipment 6 month | Payments to Acquire Property, Plant, and Equipment 9 month | Payments to Acquire Property, Plant, and Equipment 12 month |
|---|---|---|---|---|
| 2023-12-31 | 11.35M CNY 20-F · filed 2024-04-30 | |||
| 2022-12-31 | 45.83M CNY 20-F · filed 2024-04-30 | |||
| 2022-06-30 | 18.88M CNY 6-K · filed 2022-11-10 | |||
| 2021-12-31 | 29.93M CNY 20-F · filed 2024-04-30 | |||
| 2021-06-30 | 4.06M CNY 6-K · filed 2022-11-10 | |||
| 2020-12-31 | 3.25M CNY derived: 20-F 12 month − 6-K 9 month · filed 2023-05-01 | 8.01M CNY 20-F · filed 2023-05-01 | ||
| 2020-09-30 | 4.76M CNY 6-K · filed 2021-02-05 | |||
| 2019-12-31 | 7.62M CNY derived: 20-F 12 month − 6-K 9 month · filed 2022-04-29 | 12.24M CNY 20-F · filed 2022-04-29 | ||
| 2019-09-30 | 4.62M CNY 6-K · filed 2021-02-05 | |||
| 2018-12-31 | 14.41M CNY 20-F · filed 2021-04-28 | |||
| 2017-12-31 | 20.33M CNY 20-F · filed 2020-04-29 |
USD
| Period end | Payments to Acquire Property, Plant, and Equipment 3 month | Payments to Acquire Property, Plant, and Equipment 6 month | Payments to Acquire Property, Plant, and Equipment 9 month | Payments to Acquire Property, Plant, and Equipment 12 month | Payments to Acquire Property, Plant, and Equipment 12 month as first filed |
|---|---|---|---|---|---|
| 2025-12-31 | $0.00 derived: 20-F 12 month − 6-K 9 month · filed 2026-04-07 | $0.00 derived: sum of 2 quarters · filed 2026-04-07 | $7.00K 20-F · filed 2026-04-07 | ||
| 2025-09-30 | $0.00 derived: 6-K 9 month − 6-K 6 month · filed 2025-12-18 | $7.00K 6-K · filed 2025-12-18 | |||
| 2025-06-30 | $7.00K 6-K · filed 2025-10-06 | ||||
| 2024-12-31 | $38.00K derived: 20-F 12 month − 6-K 9 month · filed 2026-04-07 | $39.00K derived: sum of 2 quarters · filed 2026-04-07 | $48.00K 20-F · filed 2026-04-07 | ||
| 2024-09-30 | $1.00K derived: 6-K 9 month − 6-K 6 month · filed 2025-12-18 | $10.00K 6-K · filed 2025-12-18 | |||
| 2024-06-30 | $9.00K 6-K · filed 2025-10-06 | ||||
| 2023-12-31 | $164.00K 20-F · filed 2026-04-07 | $1.60M 20-F · filed 2024-04-30 | |||
| 2022-12-31 | $2.09M 20-F · filed 2025-04-03 | $6.64M 20-F · filed 2023-05-01 | |||
| 2022-06-30 | $2.82M 6-K · filed 2022-11-10 | ||||
| 2021-12-31 | $4.70M 20-F · filed 2022-04-29 | ||||
| 2020-12-31 | $526.00K derived: 20-F 12 month − 6-K 9 month · filed 2021-04-28 | $1.23M 20-F · filed 2021-04-28 | |||
| 2020-09-30 | $701.00K 6-K · filed 2021-02-05 | ||||
| 2019-12-31 | $1.76M 20-F · filed 2020-04-29 |